Head to Head Comparison: Envoy Medical (NASDAQ:COCH) & LogicMark (NASDAQ:LGMK)

Envoy Medical (NASDAQ:COCH) and LogicMark (NASDAQ:LGMK) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Envoy Medical and LogicMark, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	0	0	4	0	3.00
LogicMark	0	0	0	0	0.00

Envoy Medical currently has a consensus target price of $7.92, indicating a potential upside of 280.61%. Given Envoy Medical’s stronger consensus rating and higher probable upside, analysts plainly believe Envoy Medical is more favorable than LogicMark.

Profitability

This table compares Envoy Medical and LogicMark’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-4,564.57%	N/A	-125.15%
LogicMark	-146.14%	-104.48%	-79.87%

Volatility & Risk

Envoy Medical has a beta of 2.38, suggesting that its share price is 138% more volatile than the S&P 500. Comparatively, LogicMark has a beta of 1.25, suggesting that its share price is 25% more volatile than the S&P 500.

Institutional & Insider Ownership

8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 7.9% of LogicMark shares are held by institutional investors. 60.5% of Envoy Medical shares are held by insiders. Comparatively, 3.5% of LogicMark shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Envoy Medical and LogicMark”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$320,000.00	127.40	-$29.91 million	N/A	N/A
LogicMark	$9.93 million	0.07	-$14.55 million	($9.84)	-0.01

LogicMark has higher revenue and earnings than Envoy Medical.

Summary

Envoy Medical beats LogicMark on 8 of the 12 factors compared between the two stocks.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

About LogicMark

LogicMark, Inc. provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The company’s devices provide people with the ability to receive care at home and age independently and to check, manage, and monitor a loved one’s health and safety remotely. It also manufactures and distributes non-monitored and monitored personal emergency response systems, which are offered through the United States Veterans Health Administration (VHA), direct-to-consumers, healthcare durable medical equipment dealers and distributors, monitored security dealers and distributors, and its ecommerce website logicmark.com and Amazon.com. The company was formerly known as Nxt-ID, Inc. and changed its name to LogicMark, Inc. in March 2022. LogicMark, Inc. was founded in 2006 and is based in Louisville, Kentucky.